IRS investigating UnitedHealth (UNH) over alleged underpayment of taxes between 2017 and 2020 via a foreign subsidiary, STAT News reports

• IRS seeking to significantly increase taxable income for that period and potentially for subsequent years.
• UnitedHealth received the notices in March.
• The audit focuses on intercompany profit transfers, a rare form of examination given the complexity involved.

Transfer pricing examinations of this depth are uncommon; the IRS has historically reserved them for large multinationals with material intercompany profit shifting, and they tend to run for years through audit, appeals, and sometimes Tax Court before any cash changes hands. The reference to subsequent years matters more than the lookback window itself, since a sustained challenge to the transfer pricing method would carry into periods still open and raise the effective tax rate on an ongoing basis rather than as a one-time true-up. The established sequence is a reserved contingency in filings first, disclosure in the tax footnote, and only much later a cash settlement, which is why initial equity reactions in comparable cases have often retraced once the multi-year timeline set in. The peer set to watch is other healthcare and pharma names with offshore subsidiaries, where similar structures are common and where a precedent-setting IRS position could be read across. UNH already trades against a heavy regulatory and litigation backdrop, so incremental headline sensitivity is elevated relative to the broader large-cap universe. The immediate tell is whether the company discloses the matter in its next filing and whether it quantifies any range.